Literature DB >> 8040763

Kyphosis and fractures in children and young adults with cystic fibrosis.

R C Henderson1, B B Specter.   

Abstract

The purpose of this study was to examine children and adolescents with cystic fibrosis for an increased frequency of fracture and excessive thoracic kyphosis, which may result from inadequate skeletal mineralization. In a survey of 143 patients (ages 4.7 to 21.9 years; mean, 11.3 years), the fracture rate for male patients from birth to 5 years of age was higher than for female patients and both rates were comparable with those for normal children. In contrast, female patients 6 to 16 years of age with cystic fibrosis had a higher-than-normal fracture rate and a higher rate than their male counterparts. Review of the chest radiographs showed that thoracic kyphosis correlated with age and with disease severity as judged by Brasfield scoring. In the > 15-year-old age group, kyphosis exceeding 40 degrees, the upper limit of normal, was found in 77% of the female patients and 36% of the male patients. The cause of these findings is uncertain and perhaps multifactorial, but osteopenia is likely a contributing factor. As the life expectancy of patients with cystic fibrosis continues to increase, the skeletal consequences, particularly in female patients, may become increasingly significant.

Entities:  

Mesh:

Year:  1994        PMID: 8040763     DOI: 10.1016/s0022-3476(94)70194-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

Review 1.  Posture and cystic fibrosis.

Authors:  R Tattersall; M J Walshaw
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.

Authors:  H M Buntain; P J Schluter; S C Bell; R M Greer; J C H Wong; J Batch; P Lewindon; C E Wainwright
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

3.  Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis.

Authors:  Melissa S Putman; Carly E Milliren; Nicholas Derrico; Ahmet Uluer; Leonard Sicilian; Allen Lapey; Gregory Sawicki; Catherine M Gordon; Mary L Bouxsein; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2014-06-13       Impact factor: 5.958

4.  Bone mineral and body composition alterations in paediatric cystic fibrosis patients.

Authors:  Philippe Reix; Gabriel Bellon; Pierre Braillon
Journal:  Pediatr Radiol       Date:  2009-12-03

Review 5.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

6.  A prospective study of change in bone mineral density over one year in adults with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A W Horrocks; E B Mawer; J E Adams; A K Webb
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 7.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

8.  Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.

Authors:  H M Buntain; R M Greer; P J Schluter; J C H Wong; J A Batch; J M Potter; P J Lewindon; E Powell; C E Wainwright; S C Bell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

9.  Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Authors:  C M Gordon; E Binello; M S LeBoff; M E Wohl; C J Rosen; A A Colin
Journal:  Osteoporos Int       Date:  2006-03-16       Impact factor: 4.507

10.  Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study.

Authors:  Vincenzina Lucidi; Carla Bizzarri; Federico Alghisi; Sergio Bella; Beatrice Russo; Graziamaria Ubertini; Marco Cappa
Journal:  BMC Pediatr       Date:  2009-09-28       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.